Saturday, 31 March 2012

Germoloids HC Spray





1. Name Of The Medicinal Product



Germoloids® HC Spray


2. Qualitative And Quantitative Composition



Hydrocortisone 0.2% w/w



Lidocaine Hydrochloride 1.0% w/w



For excipients, see 6.1.



3. Pharmaceutical Form



Cutaneous spray solution



Colourless to pale yellow



4. Clinical Particulars



4.1 Therapeutic Indications



For the symptomatic relief of anal and perianal itch, irritation and pain, associated with external haemorrhoids.



4.2 Posology And Method Of Administration



The product is for cutaneous use.



Prime pump before initial use by depressing its top once or twice.



Adults



The product is applied by parting the buttocks if necessary, spraying once over the affected area, up to three times daily depending on the severity of the condition. The spray will operate in any orientation.



Wash hands and replace cap after use.



Elderly



The same dose applies to the elderly.



Children



The spray should not be used in children under 16 years.



4.3 Contraindications



Not to be used if sensitive to lidocaine or any of the other ingredients. Not to be used on broken or infected skin. Not to be used internally (inside the anus), or anywhere other than the anal area.



4.4 Special Warnings And Precautions For Use



Germoloids HC Spray is intended for use for limited periods and should not be used continuously for longer than 7 days. Patients should be instructed to seek medical advice if they experience persistent pain or bleeding from the anus, especially where associated with a change in bowel habit, abdominal pain, if the stomach is distended or if they are losing weight. Prompt medical treatment may be very important under such circumstances. Germoloids HC Spray should be kept away from the eyes, nose and mouth.



4.5 Interaction With Other Medicinal Products And Other Forms Of Interaction



No known interactions. Medical supervision is required if used in conjunction with other medicines containing steroids, owing to possible additive effects.



4.6 Pregnancy And Lactation



This product should not be used during pregnancy or breast-feeding. There is inadequate evidence of safety in human pregnancy. Topical administration of corticosteroids to pregnant animals can cause abnormalities of foetal development including cleft palate and intra-uterine growth retardation. There may therefore be a very small risk of such effects in the human foetus.



4.7 Effects On Ability To Drive And Use Machines



None known.



4.8 Undesirable Effects



A temporary tingling sensation may be experienced locally after initial application. Hypersensitivity to lidocaine has rarely been reported.



4.9 Overdose



Under exceptional circumstances, if Germoloids HC Spray is used excessively, particularly in young children, it is theoretically possible that adrenal suppression and skin thinning may occur. The symptoms are normally reversible on cessation of treatment.



5. Pharmacological Properties



5.1 Pharmacodynamic Properties



ATC Code: C05A A Antihaemorrhoidals for topical use – products containing corticosteroids



The preparation combines the well-known local anti-inflammatory and anti-pruritic properties of hydrocortisone and the analgesic effect of lidocaine in an aqueous spray formulation. On application, finger contact with the affected area can be avoided which makes for improved hygiene, and lessens the risk of infection.



5.2 Pharmacokinetic Properties



The active ingredients of the formulation are readily available for intimate contact with the skin and mucous membranes, as the preparation is sprayed in small droplets which dry after application to leave the active ingredients in close contact with the affected area.



Because the preparation is a clear solution, it is entirely homogeneous, and the availability of the active ingredient is optimal.



5.3 Preclinical Safety Data



There are no pre-clinical data of relevance to the prescriber, which are additional to that already included in other sections of the SPC.



6. Pharmaceutical Particulars



6.1 List Of Excipients



Cetomacrogol 1000



Citric Acid Monohydrate



Sodium Citrate



Propyl Gallate



Phenoxyethanol



Purified Water



6.2 Incompatibilities



Not applicable



6.3 Shelf Life



30 months.



6.4 Special Precautions For Storage



Do not store above 25oC.



6.5 Nature And Contents Of Container



High density polyethylene/aluminium/EAA copolymer collapsible laminate tube with metering spray pump.



Pack size: 25ml, 30ml.



The spray operates when held in any direction. The container is ozone-friendly. It is not an aerosol and does not contain any potentially irritant propellants.



6.6 Special Precautions For Disposal And Other Handling



Not applicable.



7. Marketing Authorisation Holder



Bayer plc



Bayer House



Strawberry Hill



Newbury, Berkshire



RG14 1JA



United Kingdom



Trading as Bayer plc, Consumer Care Division.



8. Marketing Authorisation Number(S)



PL 00010/0274



9. Date Of First Authorisation/Renewal Of The Authorisation



19/02/2009



10. Date Of Revision Of The Text



19/02/2009




No comments:

Post a Comment